New drug shows promise in slowing rare bone cancers
NCT ID NCT02389244
First seen Nov 01, 2025 · Last updated May 25, 2026 · Updated 21 times
Summary
This study tests whether the drug regorafenib can slow or stop the growth of bone sarcomas that have spread to other parts of the body. About 163 adults with advanced osteosarcoma, Ewing sarcoma, chondrosarcoma, or chordoma will receive either regorafenib or a placebo. The main goal is to see how many patients have no further tumor growth after a set time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EWING SARCOMAS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CHU Bretonneau
Tours, 37000, France
-
Centre Antoine Lacassagne
Nice, 06189, France
-
Centre Eugene Marquis
Rennes, 35042, France
-
Centre Francois Baclesse
Caen, 14176, France
-
Centre Georges Francois Leclerc
Dijon, 21079, France
-
Centre Léon Berard
Lyon, 69373, France
-
Centre Oscar Lambret
Lille, 59020, France
-
Gustave Roussy
Villejuif, 94800, France
-
Hopital Jean Monjoz
Besançon, 25030, France
-
Hôpital Cochin
Paris, 75014, France
-
ICM Val d'Aurelle
Montpellier, 34298, France
-
Institut Bergonie
Bordeaux, 33076, France
-
Institut Claudius Regaud
Toulouse, 31052, France
-
Institut Curie
Paris, France
-
Institut Paoli Calmettes
Marseille, 13273, France
-
Institut de Cancérologie Lucien Neuwirth (ICLN)
Saint-Priest-en-Jarez, 42270, France
-
Institut de cancerologie de l'ouest site Rene Gauducheau
Saint-Herblain, 44805, France
-
Institut de cancerologie de lorraine alexis Vautrin
Vandœuvre-lès-Nancy, 54519, France
-
La Timone University Hospital
Marseille, 13385, France
Conditions
Explore the condition pages connected to this study.